2m 2m 2m 2m 2m 2m 2m
OLEMA PHARMA (OLMA)
NASDAQ
$8.24+$0.20 (+2.43%)
Price as of Nov 12, 2026 8:23 AM EST- $703.5MMarket Cap
- -0.25%1-Year Change
- BiotechnologyIndustry
OLEMA PHARMA (OLMA)
$8.24+$0.20 (+2.43%)
OLMA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.04 | ||
Change | +$0.77 (+10.59%) | ||
Open | $7.29 | ||
High | $8.26 | ||
Low | $7.07 | ||
Previous Close | $7.27 | ||
Volume | 1,819,914 | ||
30-Day Average Volume | 1,423,217 | ||
1-Week Change | 6.63% | ||
1-Month Change | 2.81% | ||
1-Year Change | -0.25% | ||
3-Year Change | -49.21% | ||
5-Year Change | -70.32% | ||
Fundamentals | |||
Shares Outstanding | 87.5M | ||
Total Assets | $441.1M | ||
Market Cap | $703.5M | ||
Enterprise Value | $659.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$73.6M | ||
Free Cash Flow | -$47.1M | ||
EBIT | -$73.5M | ||
EBITDA | -$73.4M | ||
Net Working Capital | $354.2M | ||
EPS | -$0.73 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -11 | ||
PEG | 1 | ||
Price/Free Cash Flow | -15 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue